Elucidating the mechanism by which synthetic helper peptides sensitize Pseudomonas aeruginosa to multiple antibiotics

Area of Science:

• Microbiology
• Biochemistry
• Pharmacology

Background:

• Multi-drug resistant (MDR) bacteria, particularly Gram-negative pathogens like Pseudomonas aeruginosa, present a significant global health threat.
• There is a critical need for novel antibacterial strategies to overcome resistance and treat MDR infections effectively.

Purpose of the Study:

• To investigate the synergistic antimicrobial effects of synthetic cationic peptides with antibiotics against Pseudomonas aeruginosa.
• To elucidate the mechanism of action of the synthetic peptide D-11 in combination therapy.

Main Methods:

• Screening of synthetic cationic peptides for synergistic activity with antibiotics against P. aeruginosa.
• Characterization of peptide D-11's mechanism, including membrane interaction, proton motive force dissipation, and reactive oxygen species generation.
• In vivo efficacy testing using a P. aeruginosa abscess infection model.
• Assessment of biofilm inhibition and eradication in combination with azithromycin.

Main Results:

• Synthetic peptide D-11 demonstrated strong synergistic antimicrobial effects with multiple antibiotics against P. aeruginosa.
• D-11 enhances antibiotic efficacy by increasing membrane permeability, dissipating proton motive force, impairing respiration, and inducing reactive oxygen species.
• Combination therapy with D-11 showed enhanced therapeutic efficacy in an in vivo abscess model.
• D-11 and azithromycin combination effectively inhibited biofilm formation and eradicated established biofilms.

Conclusions:

• Synthetic cationic peptide D-11 acts as a potent adjuvant, resensitizing Gram-negative bacteria to existing antibiotics.
• The combination of D-11 with antibiotics represents a viable therapeutic approach to combat P. aeruginosa infections, including those involving biofilms.